Curcumin/gemcitabine

姜黄素/吉西他滨

Report date: 2025/11/07 14:58:38

Base Information

Drug NameCurcumin/gemcitabine

Drug Alias NameGemcitabine/curcuminSTO-2

ClassificationSmall molecules

Mechanisms of ActionRibonucleotide reductase inhibitorsDNA inhibitorsDNA (cytosine-5)-methyltransferase 1 inhibitors

TargetsRibonucleotide reductaseDNADNA (cytosine-5)-methyltransferase 1

Therapy Area/IndicationsPancreatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsYes

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesVascarta Inc

China Registration ClassN/A

Active CompaniesVascarta Inc

Inactive CompaniesN/A

Active IndicationsPancreatic Neoplasms

Inactive IndicationsN/A

ATC CodeN/A